Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Upstream Bio (UPB) EBT Margin: 2023-2025

Historic EBT Margin for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to -4,938.36%.

  • Upstream Bio's EBT Margin fell 230426.00% to -4,938.36% in Q3 2025 from the same period last year, while for Sep 2025 it was -4,364.31%, marking a year-over-year decrease of 177210.00%. This contributed to the annual value of -2,769.66% for FY2024, which is 125920.00% down from last year.
  • Per Upstream Bio's latest filing, its EBT Margin stood at -4,938.36% for Q3 2025, which was down 15.92% from -4,259.98% recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's EBT Margin ranged from a high of -1,265.54% in Q3 2023 and a low of -4,938.36% during Q3 2025.
  • Its 3-year average for EBT Margin is -3,250.13%, with a median of -2,875.10% in 2024.
  • Data for Upstream Bio's EBT Margin shows a maximum YoY tumbled of 267,005bps (in 2025) over the last 5 years.
  • Upstream Bio's EBT Margin (Quarterly) stood at -2,846.89% in 2023, then tumbled by 61,836bps to -3,465.25% in 2024, then crashed by 230,426bps to -4,938.36% in 2025.
  • Its EBT Margin was -4,938.36% in Q3 2025, compared to -4,259.98% in Q2 2025 and -4,818.02% in Q1 2025.